A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

A European clinical trial finds the drug sulthiame can cut breathing interruptions in sleep apnea, offering hope for a ...

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

In patients with OSA, increased subjective sleepiness based on ESS scores is associated with higher short-term CPAP adherence ...

Obstructive sleep apnea can cause or contribute to high blood pressure, so a new study examined which sleep apnea treatments – a CPAP machine or a mouthguard that keeps the airways open – was more ...

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea study following positive ...

The American Transportation Research Institute on April 15 launched an online survey of truck drivers on issues related to sleep apnea. ATRI said the survey results will be combined with other sleep ...

When compared with the cost of CPAP treatment, individual-level annual workplace productivity loss costs associated with obstructive sleep apnea syndrome were greater in both U.S. and U.K. populations ...